All entries by this author

The Gig is Up: The Sunshine Act Will Include CME Payments to Doctors

Dec 29th, 2011 | By
The Gig is Up: The Sunshine Act Will Include CME Payments to Doctors

Those of us who have followed the progress of the implementation of the Physician Payment Sunshine Act have been acutely aware of one potential loophole: drug companies might try to hide payments to doctors for industry-supported CME activities. That’s because these payments are not “direct” payments to doctors, but rather indirect payments. In a 2007
[continue reading...]

Share


The CME Coalition: A New Voice in the CME Industry

Nov 14th, 2011 | By

For those who have not yet heard, there is a new lobbying group in Washington, the CME Coalition. Their mission is to polish the tarnished image of industry-supported CME, in the hopes, apparently, of fending off any future legislation that would further regulate industry funding of CME. Now, if you read the organization’s mission statement,
[continue reading...]

Share


National Lipid Association: Old School Conflicts of Interest

Oct 12th, 2011 | By

Journalist Larry Husten of Cardiobrief.org just posted a fascinating article about conflicts of interest gone wild. An “expert panel” assembled by the National Lipid Association has recently published new recommendations on how to test patients for high lipids. At first glance, everything appeared legit. The authors are noted researchers in the field. The “Journal of
[continue reading...]

Share


How to get ACCME Reaccreditation: Advice

Sep 19th, 2011 | By

Reaccreditation can be an exacting process. Has your company/institution gone through the process recently? Do you have advice to share to smooth the way for others? Please leave a comment below with your advice to earn the CME community’s undying gratitude.

Share


PhRMA to Dollars for Docs: What’s Cash Got to Do With It?

Sep 15th, 2011 | By

The irrepressible ProPublica has been at it again, cross-checking, compiling and organizing the flow of cash from drug companies to doctors. Among the 12 drug companies which have revealed data (most of whom have been forced to do in the context of legal settlements) we are now up to $760 million in payments from 2009
[continue reading...]

Share


CME Message: Prescribe More EMSAM!

Sep 9th, 2011 | By

MAOIs are tricky to prescribe. Are they really worth the risks of drug and food interactions? Are they actually more effective than SSRIs for atypical depression? These are tough questions to answer. Do you trust two MECCs paid by the maker of EMSAM to give you accurate answers? God help your patients if you do.
[continue reading...]

Share


Pseudo CME about Pseudobulbar Affect

Sep 9th, 2011 | By

Stephen Stahl’s company NEI (Neuroscience Institute) produces plenty of good psychiatric education, much of it funded by subscription fees paid by doctors. But the more lucrative part of their business is churning out industry-supported CME. This is an activity funded by Avanir, maker of Nuedexta. Based on a “real patient case,” the course describes a
[continue reading...]

Share


From the Rogue’s Gallery Archives—Delaware Media Group: Sleazy MECC of the Month

Sep 9th, 2011 | By

The June 2010 issue of “Counseling Points” was body-snatched by Janssen Pharmaceuticals, and became an ACCME accredited advertisement for Risperdal Consta and Invega Sustenna. See the Carlat Psychiatry Blog exposè here.

Share


CME Rogue’s Gallery Nomination Page

Sep 9th, 2011 | By

Have you run across an accredited CME course that is so blatantly promotional that you find yourself getting queasy? Please tell us about it. We’ll investigate it, and if it meets our criteria for promotional CME, we may very well post it on our official CME Rogue’s Gallery page—and we will acknowledge you if you
[continue reading...]

Share


New Feature: CME Rogue’s Gallery

Sep 9th, 2011 | By

We’ve been beefing up our Carlat CME Institute website. Our latest feature is the “CME Rogue’s Gallery” (you can view it on the bome page) in which we keep a running list of the most blatantly promotional CME programs that cross our path. Currently we are spotlighting a program funded by Mylan Pharmaceuticals to increase
[continue reading...]

Share